medigraphic.com
ISSN 1561-3046 (Electronic)

2016, Number 3

<< Back Next >>

Rev Cub Med Mil 2016; 45 (3)

In-hospital complications of ST-segment elevation myocardial infarction

Martínez GG, Ravelo DR

Language: Spanish
References: 27
Page: 332-343
PDF size: 165.99 Kb.


ABSTRACT

Introduction: ST-segment elevation acute myocardial infarction is one of the most frequent diagnoses of admission in intensive care units at any health institution in our country.
Objective: Analyze the principal risk factors related with the acute myocardial infarction and its complications in the admission, as well as these complications predictors.
Method: A descriptive, prospective study was conducted in 272 consecutive patients who were admitted in Coronary Intensive Care Unit of Dr. Carlos J. Finlay Central Military Hospital. ST-segment elevation myocardial infarction was their diagnosis. They period studied was from September 2013 to August 2016.
Results: The patients` median age was 63.4 ± 11.7 years, and 168 (61.8 %) were male. The main risk factors were hypertension and smoking (66.5 % in both cases). One hundred nine (109) patients suffered complications in hospital; the post-infarct angina was the most frequent (34.9 %). The association among cardiogenic shock and mechanical complications with mortality was significant (p< 0.007 and p< 0.001, respectively). Independent associations were found between age ? 60 years, the Killip-Kimball functional classification ? II, non-performing percutaneous coronary intervention were prognostic factors for adverse events during admission.
Conclusions: The complications of ST-segment elevation myocardial infarction during hospital admittance are not frequent. There are prognosis factors of complications like advanced age, functional Killip-Kimball classification ? II and nonperforming percutaneous coronary intervention.


REFERENCES

  1. World Health Organization. World Health Statistics 2014. Geneve: WHO Press; 2015 [cited 2015 Jun 16]. Available from: http://www.who.int/gho/publications/world_health_statistics/en/

  2. Programa de las Naciones Unidas para el desarrollo. Informe sobre Desarrollo Humano 2013. El ascenso del Sur: progreso humano en un mundo diverso. Nueva York: PNUD; 2013.

  3. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2015. La Habana: MINSAP; 2016.

  4. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol. 2015;68(12):1125.e1-e64.

  5. Aranda-Granados P, González-López M, Gutiérrez-de Loma J. Infarto agudo de miocardio y sus complicaciones. ¿Cuáles son las indicaciones quirúrgicas actuales? Cardiocore. 2011;46(2):61-4.

  6. Jiménez-Candil J, Díaz-Castro O, Barrabés JA, García de la Villa B, Bodí VP, López RP. Actualización en cardiopatía isquémica y cuidado críticos cardiológicos. Rev Esp Cardiol. 2013;66(3):198-204.

  7. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. ACCF/AHA Guidelines for the management of ST-Elevation Myocardial Infarction. A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guideline. J Am Coll Cardiol. 2013 Jan 29;61(4):e78-140.

  8. Steg G, James SK, Atar D, Badano LP, Blomstrom C, Borger MA, et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2013;66(1):53.e1-e46.

  9. Bradley EH, Curry LA, Spatz ES. Hospital strategies for reducing riskstandardized mortality rates in acute myocardial infarction. Ann Intern Med. 2012;156:618-26.

  10. Davidson ChJ, Bonow RO. Cateterismo cardíaco. En: Braunwald. Tratado de Cardiología. 9na ed. Barcelona: Elsevier; 2013. p. 388-411.

  11. Rizo GO, Ramírez JI, Pérez D, Novo L, Acosta F, Cordero Q, et al. Valor predictivo de muerte y complicaciones intrahospitalarias de los modelos de estratificación de riesgo en pacientes con infarto miocárdico agudo. Rev Fed Arg Cardiol. 2011;40(1):57-64.

  12. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Documento de consenso de expertos. Tercera definición universal del infarto de miocardio. Rev Esp Cardiol. 2013; 66(2):132.e1-e15.

  13. Canto J, Rogers W, Rogers W. Diferencias clínicas del Infarto Agudo de Miocardio en relación con la edad y el sexo. JAMA. 2012 Feb; 307(8):813-22.

  14. Rubini GM, Reiter M, Twerenbold R, Reichlin T, Wildi K, Haaf P, et al. Sexspecific chest pain characteristics in the early diagnosis of acute myocardial infarction. JAMA Intern Med. 2014;174:241-9.

  15. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011;124:40-7.

  16. De los Reyes ML. La Unidad Coronaria y el anciano con cardiopatía isquémica en España: De la información epidemiológica a la realidad clínica. Rev Esp Cardiol. 2005;58(Suppl 3):44-58.

  17. Diez J, Frohlich ED. A translational approach to hypertensive heart disease. Hypertension. 2010;55:1-8.

  18. Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43:1006-13.

  19. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368:2004-13.

  20. Buerke M, Prondzinsky R, Lemm H, Dietz S, Buerke U, Ebelt H, et al. Intraaortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock-review of the current evidence. Artif Organs. 2012;36:505-11.

  21. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:188-97.

  22. Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. J Am Med Assoc. 2011;305:1677-84.

  23. Parikh NI, Gona P, Larson MG. Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart Study. Circulation. 2009;119:1203-10.

  24. Mahon NG, O´rorke C, Codd MB, et al. Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart. 2009;81:478-82.

  25. Charchar FJ, Bloomer LD, Barnes TA, Cowley MJ, Nelson CP, Wang Y, et al. Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet. 2012;379:915-22.

  26. Nielsen PH, Terkelsen CJ, Nielsen TT, Thuesen L, Krusell LR, Thayssen P, et al. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial). Am J Cardiol. 2011;108:776-81.

  27. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211-9.




2020     |     www.medigraphic.com